Gilead Sciences reported strong fourth-quarter earnings with significant growth in its HIV and oncology segments.

Reports Q4 revenue $5.47B, consensus $5.44B. “I am pleased to announce Exelon (EXC) has delivered against our financial goals for the third ...

Reports Q4 revenue $1.23B, consensus $1.25B. “Our fourth quarter results highlight our ability to rapidly increase production and execute on ...

Ecolab Inc (NYSE:ECL) shares are trading higher after the company reported fourth-quarter sales growth of 2% year-on-year to ...

WEC Energy boosts its dividend for the 22nd year, with strong growth prospects and a $28B investment plan. Find out why WEC ...

As DoorDash clocked 42 million monthly users with order frequency at an all-time high, its grocery, retail vertical saw ...

Shares of CVS Health (CVS) surged in premarket trading Wednesday after the health insurance and pharmacy giant reported ...

Biotech giant Biogen Inc (NASDAQ:BIIB) is scheduled to report fourth-quarter earnings on 12 February. The Wall Street ...

Astera Labs reported a strong Q4, beating revenue expectations by 10% and tripling its earnings per share. Find out why I ...

Restaurant Brands International reported better-than-expected fourth-quarter results Wednesday, sending shares higher in premarket trading.

The board recommended distributing 34 fils per share as the final dividend for 2024, taking the full-year dividend to 54 fils ...

DoorDash Inc. (DASH) reported its Q4 2024 earnings, meeting Wall Street expectations with an earnings per share (EPS) of $0.33, on par with the forecast. The company also reported revenues of $2.87 ...